Do you want to read an article? Please log in or register.
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
Pneumonia
![](https://cdn.healthbook.network/wp-content/uploads/2018/03/like_hb.png)